Research, Reconstra Utama Integra, Jakarta, DKI Jakarta, Indonesia
Biostatistics, Universitas Indonesia, Depok, Jawa Barat, Indonesia.
BMJ Open. 2022 Aug 11;12(8):e058570. doi: 10.1136/bmjopen-2021-058570.
Vaccine hesitancy remains a major barrier to immunisation coverage worldwide. We explored influence of hesitancy on coverage and factors contributing to vaccine uptake during a national measles-rubella (MR) campaign in Indonesia.
Secondary analyses of qualitative and quantitative data sets from existing cross-sectional studies conducted during and around the campaign.
Quantitative data used in this assessment included daily coverage reports generated by health workers, district risk profiles that indicate precampaign immunisation programme performance, and reports of campaign cessation due to vaccine hesitancy. We used t-test and χ tests for associations. The qualitative assessment employed three parallel national and regional studies. Deductive thematic analysis examined factors for acceptance among caregivers, health providers and programme managers.
Coverage data were reported from 6462 health facilities across 395 districts from 1 August to 31 December 2018. The average district coverage was 73%, with wide variation between districts (2%-100%). One-third of districts fell below 70% coverage thresholds. Sixty-two of 395 (16%) districts paused the campaign due to hesitancy. Coverage among districts that never paused campaign activities due to hesitancy was significantly higher than rates for districts ever-pausing the campaign (81% vs 42%; p<0.001). Precampaign adequacy of district immunisation programmes did not explain coverage gaps (p=0.210). Qualitative analysis identified acceptance enablers including using digital health monitoring and feedback systems, increasing caregiver knowledge and awareness, making immunisation social norm, effective cross-sectoral collaboration, conducive service environment and positive experiences for mothers and children. Barriers included misinformation diffusion on social media, halal-haram issues, lack of healthcare provider knowledge, negative family influences and traditions, previous poor experiences and misinformation on adverse events.
Barriers to vaccine uptake contributed to coverage gaps during national MR campaign in Indonesia. A range of supply-related and demand-related strategies were identified to address hesitancy contributors. Advancing a portfolio of tailored multilevel interventions will be critical to enhance vaccine acceptance.
疫苗犹豫仍然是全球疫苗接种覆盖率的主要障碍。我们探讨了在印度尼西亚全国麻疹-风疹(MR)运动期间和期间,犹豫对覆盖率的影响以及导致疫苗接种率的因素。
对现有横断面研究的定性和定量数据集进行二次分析,这些研究是在运动期间和周围进行的。
本评估中使用的定量数据包括卫生工作者每天生成的覆盖率报告、表明战前免疫规划绩效的地区风险概况以及因疫苗犹豫而停止运动的报告。我们使用 t 检验和 χ 检验进行关联。定性评估采用了三项平行的国家和区域研究。演绎主题分析检查了照顾者、卫生提供者和方案管理人员接受疫苗的因素。
从 2018 年 8 月 1 日至 12 月 31 日,在 395 个地区的 6462 个卫生机构报告了覆盖率数据。平均地区覆盖率为 73%,地区之间差异很大(2%-100%)。三分之一的地区覆盖率低于 70%的覆盖率阈值。由于犹豫,395 个地区中有 62 个(16%)暂停了运动。由于犹豫从未暂停过运动活动的地区的覆盖率明显高于曾暂停过运动的地区的比率(81%比 42%;p<0.001)。战前地区免疫规划的充足性并不能解释覆盖率差距(p=0.210)。定性分析确定了接受的促成因素,包括使用数字健康监测和反馈系统、增加照顾者的知识和认识、使免疫成为社会规范、有效的跨部门合作、有利的服务环境以及母亲和儿童的积极体验。障碍包括社交媒体上的错误信息传播、清真-非清真问题、缺乏医疗保健提供者的知识、负面家庭影响和传统、以前的不良体验和不良事件的错误信息。
疫苗接种的障碍导致了印度尼西亚全国麻疹-风疹运动期间的覆盖率差距。确定了一系列与供应相关和需求相关的策略来解决犹豫不决的原因。推进一系列量身定制的多层次干预措施将是提高疫苗接受度的关键。